Symphogen AS Strategic SWOT Analysis Review [Report Updated: 29112017] Prices from USD $125

00:05 EST 18 Dec 2017 | BioPortfolio Reports

Symphogen AS Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Business description A detailed description of the company's operations and business divisions.

Corporate strategy GlobalData's summarization of the company's business strategy.

SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities A list of key manufacturing facilities of the company.


Symphogen A/S Symphogen is a biopharmaceutical company that specializes in the field of recombinant antibody mixtures for therapeutic use in cancer. The company focuses on developing superior monoclonal antibody mAb mixture therapeutics to enhance the lives of patients with cancer and other diseases with significant unmet medical needs. Its product pipeline provides novel approaches to a wide range of cancer types including metastatic colorectal cancer mCRC, glioblastoma GBM, solid tumor malignancies and METamplified solid tumors and partner targets. It has collaborations for the development of antibody therapeutics in immunooncology with Shire and infectious disease area with Genentech. Symphogen has offices in Denmark and New Jersey, the US.

Symphogen AS Key Recent Developments

Sep 14,2016: Symphogen Names New Chief Financial Officer

Aug 18,2016: Symphogen's Founding CEO Kirsten Drejer Steps Down and Becomes Executive Director

May 11,2016: Symphogen Announces the Appointment of Jeffrey H. Buchalter and Christoffer Soderberg as NonExecutive Directors

Reasons to Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Original Article: Symphogen AS Strategic SWOT Analysis Review [Report Updated: 29112017] Prices from USD $125


More From BioPortfolio on "Symphogen AS Strategic SWOT Analysis Review [Report Updated: 29112017] Prices from USD $125"

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...